Levitee Labs Partners With Canntab Therapeutics To Provide Alternatives To Opioid Medications

Levitee Labs Inc. (Levitee), an integrative wellness company and addiction treatment provider organization with a diversified portfolio of health care and wellness assets, has entered into a strategic partnership via a services agreement with Canntab Therapeutics Limited (Canntab). Canntab provides cannabinoid and terpene blends in hard pill form for therapeutic applications available in multiple doses and timed-release combinations.

Levitee currently owns five addiction clinics and three specialized pharmacies which have conducted more than 35,000 consumer visits in the last 12 months. Pursuant to the Agreement, Levitee will, where applicable, inform consumers throughout its ecosystem of specialized clinics and . . .